OVERVIEW

Antibodies as Drugs: Evolving Designs, Formats and Approaches is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Feb 22 - 25, 2027 at Fairmont Banff Springs, Banff, Alberta, Canada.

Description:
To mark 40 years since the approval of the first monoclonal antibody for therapeutic use, this conference will highlight the major advances that have accompanied the field. While innovation continues with traditional formats, these large molecules now encompass conjugates, multiple targets, target selectivity, and de novo design alongside combinations and innovative dosing paradigms. These innovations have afforded antibodies unparalleled success in combatting rare disease for a few patients to deployment to millions in record time during the recent pandemic. 

This Keystone Symposia conference on Antibodies as Drugs: Evolving Design, Formats and Approaches will expose attendees to the most cutting-edge technologies employed in antibody development. Each session will build and expand on the last, allowing for deep interrogation of the innovations across indications and platforms. Sessions will delve into multispecific antibodies and the use of combinations or engagement of specific targets for specific indications, selectively active antibodies and novel platforms for conditional engagement, exogenous targets and advancements in pathogens, and novel scaffolds including other formats and antibody-like molecules. 

This conference will bring together the innovators across different modalities to share the major strides gained and apply these advances to new clinical indications for patients. Joint programming with Computational Drug Discovery: Tools Across the Translational Pipeline includes a session for attendees to hear from pioneers in the field to explore how computational approaches to antibody design can be applied across these modalities. 

By showcasing the innovations that have established antibodies as transformative therapeutics, this meeting positions itself as a unique forum for advancing the next generation of antibody-based approaches and shaping the future of biologic drug development. 

KEY DATES

Registrations Open
14 Nov, 2026
Registrations Open
Event Start Date
22 Feb, 2027
Event Start Date
Event End Date
25 Feb, 2027
Event End Date

TARGET AUDIENCE

Pharmacist

SPECIALITIES

Pharmacy and Medicine

SUGGESTED HOTELS

CONFERENCE VENUE

LocationFairmont Banff Springs
405 Spray Avenue

RELATED CONFERENCES & LIVE WEBINARS